In June 2025 Matcher Technologies Ltd received significant growth investment from Reprotech LLC – the US-based specialist in cryostorage technology solutions.

Since then  Matcher Technologies Ltd and Reprotech LLC have formed a strategic partnership built on shared values of innovation, quality, and exceptional service. Our complementary technologies create a seamless, end-to-end digital chain of custody for IVF centres, from on-site witnessing and cryo management to off-site cryo storage at purpose-built biorepositories. Together, we aim to eliminate pain-points, reduce risk and deliver a seamless and streamlined experience. 

Matcher Cryo Chain™

Matcher Cryo Chain™ functionality allows integration with off-site cryo storage providers. We are currently collaborating with Reprotech on the first Cryo Chain™ integration.
Matcher Cryo Chain™ helps ensure a secure, compliant, and fully traceable digital chain of custody for cryo preserved materials – from the moment they leave the fertility centre, to their arrival into off-site storage and back.

  • Helps ensure secure, traceable handling of cryo preserved items from lab to off-site storage and back
  • Maintains comprehensive audit trails for safety, compliance, and reporting
  • Provides an Insights dashboard for sending and receiving of items.
  • Uses API-based data exchange to connect with off-site storage providers, enabling smooth interoperability
  • Sets a new standard in cryo item tracking for fertility centres
  • Positions your clinic as a leader in secure, tech-enabled fertility care

Discover how Matcher Cryo ChainTM in partnership with Reprotech helps secure every step in the digital chain of custody of the cryo journey.

View PDF

What the partnership means

This growth is underlined by our complimentary products – with Matcher’s witnessing and traceability system which extends into IVF centres’ on-site cryostorage; through to Reprotech’s cryo-management system and into their logistics and transportation system and finally to off-site storage at their purpose-built biorepositories. The partnership marks a significant step towards building the first truly comprehensive platform to digitally document every step of the IVF process – eliminating pain-points and delivering a seamless and streamlined experience.

We are keen to continue to take advantage of the growing demand from fertility centres and donor banks around the world. They are realising that manual witnessing can no longer be defended, and that competitors in the market don’t bring the 20 years of focussed expertise and excellence to their products that we do.

We remain fully committed to delivering exceptional service and support to our existing end users and combined with the accelerated innovation this partnership brings, we see strong potential for added value through additional global time-zone support, enhanced features, new integrations, and a more agile product release roadmap.

George Heywood- CEO of IMT Matcher and CGO of Reprotech

Matcher operates as a distinct subsidiary within ReproTech’s broader business, and operates from its UK headquarters. George Heywood remains CEO of Matcher and has taken on additional responsibilities as Chief Growth Officer at Reprotech. The rest of the team remain the same, with the same products, the same processes and the same distributors.

“I’m excited to continue leading IMT Matcher while also taking on the role of Chief Growth Officer at Reprotech. This partnership aligns perfectly with our mission and gives us an even stronger platform to support clinics worldwide. While our products, processes, and team remain exactly the same, joining Reprotech’s broader family allows us to scale our impact and explore new opportunities for growth. It’s a natural next step for Matcher, and I’m proud to help drive this new chapter.”

Brad Senstra CEO of Reprotech commented, “We are certainly thrilled to welcome Matcher into the Reprotech family – the teams, technologies, mission and values align perfectly with ours, and we see Matcher as an integral part of ReproTech’s continuing growth and geographic expansion.”

From Matcher’s perspective, Reprotech’s reputation as a trusted cryostorage solutions partner—with over 35 years of experience—and their dedication to advancing traceability in fertility care make them an ideal partner. Together, we are driving innovation and enhancing our service offerings in both domestic and international markets.

Matcher Technologies Ltd was advised by Clearwater, Brabners LLP, and Claritas Tax. Reprotech was advised by Shoosmiths LLP, BDO LLP, and Armstrong Teasdale LLP.

Discover more about Reprotech LLC

Overview

Demo

Distributors

Contact